West Pharmaceutical Services Inc.
Annette F Favorite (Sr. VP & Chief HR Officer) sells WST shares
About this filing
West Pharmaceutical Services Inc. (WST) filed Form 4 (insider transaction) with the SEC on Sep 15, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Annette F Favorite · Sr. VP & Chief HR Officer
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | M · exercise or conversion of a derivative | +2,500 | $89.64 | $224,100.00 | 24,317.8098 | Direct |
| Sep 11, 2026 | S · open-market sale | −2,500 | $345.00 | $862,500.00 | 21,817.8098 | Direct |
| Sep 14, 2026 | M · exercise or conversion of a derivative | +2,500 | $89.64 | $224,100.00 | 24,317.8098 | Direct |
| Sep 14, 2026 | S · open-market sale | −2,500 | $355.00 | $887,500.00 | 21,817.8098 | Direct |
| Sep 15, 2026 | M · exercise or conversion of a derivative | +2,524 | $89.64 | $226,251.36 | 24,341.8098 | Direct |
| Sep 15, 2026 | S · open-market sale | −2,524 | $365.00 | $921,260.00 | 21,817.8098 | Direct |
| Sep 11, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1 | −2,500 | $0.00 | $0.00 | 5,024 | Direct |
| Sep 14, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1 | −2,500 | $0.00 | $0.00 | 2,524 | Direct |
| Sep 15, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1 | −2,524 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019.
More WST filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Sep 10, 2026
- 4
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.